Unichem Laboratories
503.30
-3.10(-0.61%)
Market Cap₹3,543.52 Cr
PE Ratio28.42
IndustryHealthcare
Company Performance:
1D-0.61%
1M-1.08%
6M-20.62%
1Y-24.75%
5Y+93.28%
View Company Insightsright
Latest news about Unichem Laboratories
More news about Unichem Laboratories
20Mar 25
Unichem Laboratories Boosts API Capacity with ₹200 Crore Expansion at Pithampur Plant
Unichem Laboratories has completed the first phase of expansion at its API plant in Pithampur, investing ₹200 crore to add 210 KL of capacity. This nearly doubles the facility's capacity from 259.50 KL to 469.50 KL. The expansion, funded through internal accruals and bank borrowings, aims to serve internal requirements and potentially capture a larger market share in the API segment. The existing capacity utilization was around 70% before the expansion.
02Mar 25
Unichem Laboratories' Pithampur API Facility Inspection Concludes; Company Announces Sale of Mumbai Property
Unichem Laboratories underwent a USFDA inspection at its Pithampur API facility, resulting in four procedural observations. The company will respond within 15 days. Separately, Unichem's Board approved the sale of a 3.40-acre Mumbai property to Macrotech Developers for ₹279 crores, with completion expected by June 30, 2025. The property's book value is ₹2.18 crores, indicating a significant gain from the sale.
02Mar 25
Unichem Laboratories to Sell Jogeshwari Property for Rs 279 Crore
Unichem Laboratories has approved the sale of a 3.40-acre property in Mumbai to Macrotech Developers Limited for Rs 279 crore. The property, previously the company's registered office, has a book value of Rs 2.18 crore. The transaction is expected to complete by June 30, 2025, and will not impact ongoing business operations. This move is part of Unichem's strategy to monetize non-core assets and focus on its pharmaceutical activities.
Unichem Laboratories
503.30
-3.10
(-0.61%)
1 Year Returns:-24.75%
Industry Peers
Sun Pharmaceutical
1,602.00
(-0.90%)
Divis Laboratories
6,057.00
(+0.51%)
Cipla
1,548.30
(-1.67%)
Torrent Pharmaceuticals
3,531.60
(-0.97%)
Dr Reddys Laboratories
1,300.80
(-1.21%)
Mankind Pharma
2,585.40
(+0.22%)
Zydus Life Science
1,036.90
(-0.75%)
Lupin
2,046.00
(+0.13%)
Alkem Laboratories
5,500.50
(+0.96%)
Abbott
30,910.00
(-0.23%)